Home Clinical Trial Updates

Clinical Trial Updates

Attendees during the San Antonio Breast Cancer Symposium (SABCS) being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Photo courtesy © 2019 AACR/SABCS / Todd Buchanan.

SABCS 2019: Ribociclib + Letrozole – Similar Results as Chemo in...

Peter Hofland, Ph.D -
The ASH Store at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center. Photo courtesy © 2019. ASH/Scott Morgan.

ASH 2019: Brentuximab Vedotin in Combination with Nivolumab in Frontline and...

Editorial Team -
Attendees and Speakers during Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies at the American Society of Hematology 60th Annual Meeting at the Orange County Convention Center on, Friday December 6, 2019. Photo courtesy © 2019 ASH/Matt Herp 2019

ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and...

Peter Hofland, Ph.D -
General Views during at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center. Photo Courtesy © 2019 ASH/Danny Morton.

Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes

Peter Hofland, Ph.D -

Combination of Fimepinostat + Venetoclax Generally Well-tolerated

Peter Hofland, Ph.D -
Doctor discussing treatment options with a patient.

Connecting Patients to Clinical Trials can Lead to New and Better...

Editorial Team -
Human kidney cross section. Photo courtesy: 2019 Fotolia

Tivozanib Improved PFS and was better Tolerated Compared with Sorafenib in...

Peter Hofland, Ph.D -
Glioblastoma with extreme nuclear enlargement.

Tasadenoturev + Pembrolizumab Shows Clinical Benefit in Recurrent Glioblastoma

Peter Hofland, Ph.D -
Featured Image: Diffuse intrinsic pontine glioma (DIPG) is a rare, deadly childhood brain cancer. Here, a confocal micrograph shows DIPG cells, grown from patient cells, in culture. The cells are expressing several proteins, including: DAPI (blue, in the cell nuclei); vimentin (red, a protein marker of neural stem/precursor cells and glioma cells); and Nestin (green, also a protein marker of neural stem/precursor cells and glioma cells). Photo Courtesy: Shawn Gillespie, Monje Laboratory, Stanford Medicine.

Drug Combination Shows Promise Against Lethal Childhood Brain Cancers

Peter Hofland, Ph.D -
Doctor talking a with patient in hospital exam room. Photo courtesy: 2019 Fotolia

Phase III HERO Study of Oral Relugolix in Advanced Prostate Cancer...

Peter Hofland, Ph.D -
123...19Page 1 of 19

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.